307 related articles for article (PubMed ID: 25799171)
1. Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials.
Kim JS; Park J; Lim SY; Oh YM; Yoo KH; Park YB; Sheen SS; Kim MJ; Carriere KC; Jung JY; Park HY
PLoS One; 2015; 10(3):e0119948. PubMed ID: 25799171
[TBL] [Abstract][Full Text] [Related]
2. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.
Decramer M; Dahl R; Kornmann O; Korn S; Lawrence D; McBryan D
Respir Med; 2013 Feb; 107(2):223-32. PubMed ID: 23219347
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severity.
Mahler DA; Buhl R; Lawrence D; McBryan D
Pulm Pharmacol Ther; 2013 Jun; 26(3):348-55. PubMed ID: 23434446
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.
Cope S; Zhang J; Williams J; Jansen JP
BMC Pulm Med; 2012 Jun; 12():29. PubMed ID: 22732017
[TBL] [Abstract][Full Text] [Related]
6. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
Buhl R; Dunn LJ; Disdier C; Lassen C; Amos C; Henley M; Kramer B;
Eur Respir J; 2011 Oct; 38(4):797-803. PubMed ID: 21622587
[TBL] [Abstract][Full Text] [Related]
7. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
Chong J; Karner C; Poole P
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.
Girodet PO; Jasnot JY; Le Gros V; Decuypère L; Cao W; Devouassoux G
Respir Med; 2017 Jul; 128():92-101. PubMed ID: 28566230
[TBL] [Abstract][Full Text] [Related]
9. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
Donohue JF; Fogarty C; Lötvall J; Mahler DA; Worth H; Yorgancioglu A; Iqbal A; Swales J; Owen R; Higgins M; Kramer B;
Am J Respir Crit Care Med; 2010 Jul; 182(2):155-62. PubMed ID: 20463178
[TBL] [Abstract][Full Text] [Related]
10. Indacaterol therapy in patients with COPD not receiving other maintenance treatment.
Decramer M; Rossi A; Lawrence D; McBryan D
Respir Med; 2012 Dec; 106(12):1706-14. PubMed ID: 23031496
[TBL] [Abstract][Full Text] [Related]
11. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.
Decramer ML; Chapman KR; Dahl R; Frith P; Devouassoux G; Fritscher C; Cameron R; Shoaib M; Lawrence D; Young D; McBryan D;
Lancet Respir Med; 2013 Sep; 1(7):524-33. PubMed ID: 24461613
[TBL] [Abstract][Full Text] [Related]
12. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.
Inui N; Matsushima S; Kato S; Yasui H; Kono M; Fujisawa T; Enomoto N; Nakamura Y; Toyoshima M; Suda T
Int J Chron Obstruct Pulmon Dis; 2015; 10():1139-46. PubMed ID: 26124653
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
14. Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.
McKeage K
Drugs; 2012 Mar; 72(4):543-63. PubMed ID: 22356291
[TBL] [Abstract][Full Text] [Related]
15. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
Mahler DA; D'Urzo A; Bateman ED; Ozkan SA; White T; Peckitt C; Lassen C; Kramer B;
Thorax; 2012 Sep; 67(9):781-8. PubMed ID: 22544891
[TBL] [Abstract][Full Text] [Related]
16. Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naïve COPD patients: A pooled analysis.
Muro S; Yoshisue H; Kostikas K; Olsson P; Gupta P; Wedzicha JA
Respirology; 2020 Apr; 25(4):393-400. PubMed ID: 31339215
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.
Cope S; Capkun-Niggli G; Gale R; Lassen C; Owen R; Ouwens MJ; Bergman G; Jansen JP
Value Health; 2012 May; 15(3):524-33. PubMed ID: 22583463
[TBL] [Abstract][Full Text] [Related]
18. Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.
Jones PW; Mahler DA; Gale R; Owen R; Kramer B
Respir Med; 2011 Jun; 105(6):892-9. PubMed ID: 21397482
[TBL] [Abstract][Full Text] [Related]
19. The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.
Kerstjens HA; Deslée G; Dahl R; Donohue JF; Young D; Lawrence D; Kornmann O
Pulm Pharmacol Ther; 2015 Jun; 32():101-8. PubMed ID: 25743376
[TBL] [Abstract][Full Text] [Related]
20. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
Matsushima S; Inui N; Yasui H; Kono M; Nakamura Y; Toyoshima M; Shirai T; Suda T
Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]